Literature DB >> 32102574

2D parametric contrast time-density analysis for the prediction of complete aneurysm occlusion at six months' post-flow diversion stent.

Ahmed E Hussein1, Meghana Shownkeen1, Andre Thomas1, Christopher Stapleton1, Denise Brunozzi1, Jessica Nelson2, John Naumgart2, Andreas Linninger1,3, Gursant Atwal1, Ali Alaraj1,3.   

Abstract

OBJECTIVE: Indications for the treatment of cerebral aneurysms with flow diversion stents are expanding. The current aneurysm occlusion rate at six months ranges between 60 and 80%. Predictability of complete vs. partial aneurysm occlusion is poorly defined. Here, we evaluate the angiographic contrast time-density as a predictor of aneurysm occlusion rate at six months' post-flow diversion stents.
METHODS: Patients with unruptured cerebral aneurysms proximal to the internal carotid artery terminus treated with single flow diversion stents were included. 2D parametric parenchymal blood flow software (Siemens-Healthineers, Forchheim, Germany) was used to calculate contrast time-density within the aneurysm and in the proximal adjacent internal carotid artery. The area under the curve ratio between the two regions of interests was assessed at baseline and after flow diversion stents deployment. The area under the curve ratio between completely vs. partially occluded aneurysms at six months' follow-up was compared.
RESULTS: Thirty patients with 31 aneurysms were included. Mean aneurysm diameter was 8 mm (range 2-28 mm). Complete occlusion was obtained in 19 aneurysms. Younger patients (P = 0.006) and smaller aneurysms (P = 0.046) presented higher chance of complete obliteration. Incomplete occlusion of the aneurysm was more likely if the area under the curve contrast time-density ratio showed absolute (P = 0.001) and relative percentage (P = 0.001) decrease after flow diversion stents deployment. Area under ROC curve was 0.85.
CONCLUSION: Negative change in the area under the curve ratio indicates less contrast stagnation in the aneurysm and lower chance of occlusion. These data provide a real-time analysis after aneurysm treatment. If validated in larger datasets, this can prompt input to the surgeon to place a second flow diversion stents.

Entities:  

Keywords:  Aneurysm occlusion; cerebral aneurysm; contrast time-density; flow diversion; pipeline embolization device

Mesh:

Substances:

Year:  2020        PMID: 32102574      PMCID: PMC7446590          DOI: 10.1177/1591019920908205

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  26 in total

Review 1.  Alteration of intra-aneurysmal hemodynamics for flow diversion using enterprise and vision stents.

Authors:  Markus Tremmel; Jianping Xiang; Sabareesh K Natarajan; L Nelson Hopkins; Adnan H Siddiqui; Elad I Levy; Hui Meng
Journal:  World Neurosurg       Date:  2010 Aug-Sep       Impact factor: 2.104

2.  An in vitro study of silk stent morphology.

Authors:  Thaweesak Aurboonyawat; Raphaël Blanc; Paul Schmidt; Michel Piotin; Laurent Spelle; Amir Nakib; Jacques Moret
Journal:  Neuroradiology       Date:  2010-10-28       Impact factor: 2.804

3.  A novel grading scale for the angiographic assessment of intracranial aneurysms treated using flow diverting stents.

Authors:  C J O'kelly; T Krings; D Fiorella; T R Marotta
Journal:  Interv Neuroradiol       Date:  2010-07-19       Impact factor: 1.610

4.  Angiographic assessment of the efficacy of flow diverter treatment for cerebral aneurysms.

Authors:  Chander Sadasivan; Ronak Dholakia; Lissa Peeling; Philipp Gölitz; Arnd Doerfler; Baruch B Lieber; David J Fiorella; Henry H Woo
Journal:  Interv Neuroradiol       Date:  2019-07-11       Impact factor: 1.610

5.  Predictors of Incomplete Occlusion following Pipeline Embolization of Intracranial Aneurysms: Is It Less Effective in Older Patients?

Authors:  N Adeeb; J M Moore; M Wirtz; C J Griessenauer; P M Foreman; H Shallwani; R Gupta; A A Dmytriw; R Motiei-Langroudi; A Alturki; M R Harrigan; A H Siddiqui; E I Levy; A J Thomas; C S Ogilvy
Journal:  AJNR Am J Neuroradiol       Date:  2017-09-14       Impact factor: 3.825

6.  Effects of flow-diverting device oversizing on hemodynamics alteration in cerebral aneurysms.

Authors:  F Mut; J R Cebral
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-03       Impact factor: 3.825

7.  Validation of cerebral arteriovenous malformation hemodynamics assessed by DSA using quantitative magnetic resonance angiography: preliminary study.

Authors:  Sophia F Shakur; Denise Brunozzi; Ahmed E Hussein; Andreas Linninger; Chih-Yang Hsu; Fady T Charbel; Ali Alaraj
Journal:  J Neurointerv Surg       Date:  2017-02-24       Impact factor: 5.836

8.  Pipeline endovascular device for the treatment of intracranial aneurysms at the level of the circle of Willis and beyond: multicenter experience.

Authors:  M Martínez-Galdámez; A Romance; P Vega; A Vega; J L Caniego; L Paul; I Linfante; G Dabus
Journal:  J Neurointerv Surg       Date:  2014-09-08       Impact factor: 5.836

9.  Simple measurement of aneurysm residual after treatment: the SMART scale for evaluation of intracranial aneurysms treated with flow diverters.

Authors:  Iris Quasar Grunwald; M Kamran; R A Corkill; A L Kühn; I S Choi; S Turnbull; D Dobson; K Fassbender; D Watson; M J Gounis
Journal:  Acta Neurochir (Wien)       Date:  2011-10-16       Impact factor: 2.216

10.  Blood flow in intracranial aneurysms treated with Pipeline embolization devices: computational simulation and verification with Doppler ultrasonography on phantom models.

Authors:  Anderson Chun On Tsang; Simon Sui Man Lai; Wai Choi Chung; Abraham Yik Sau Tang; Gilberto Ka Kit Leung; Alexander Kai Kei Poon; Alfred Cheuk Hang Yu; Kwok Wing Chow
Journal:  Ultrasonography       Date:  2015-01-31
View more
  1 in total

1.  Retrospective analysis of intracranial aneurysms after flow diverter treatment including color-coded imaging (syngo iFlow) as a predictor of aneurysm occlusion.

Authors:  Andreas Simgen; Christine Mayer; Michael Kettner; Ruben Mühl-Benninghaus; Wolfgang Reith; Umut Yilmaz
Journal:  Interv Neuroradiol       Date:  2021-06-09       Impact factor: 1.764

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.